fda compounding semaglutide enforcement november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines FDA to Restrict Ingredients Used

In recent years, GLP-1 (glucagon-like peptide-1) receptor agonists have surged in popularity for their role in managing weight loss and metabolic health

When p 0.05, we used one-way ANOVA to compare differences between groups

Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists

Yes restoring SCFA production, mucosal integrity, and microbial diversity helps maintain natural GLP-1 signaling without medication

Quercetin suppresses apoptosis of chondrocytes induced by IL-1 via inactivation of p38 MAPK signaling pathway

These treatments are currently undergoing clinical trials for expanded usage in pediatric populations and to target broader cardiometabolic and liver conditions, thus rapidly expanding the treatable patient pool